Observational Study of Hand Function After Distal Transradial Access for Angiography (RATATOUILLE)

March 7, 2021 updated by: Dr Thomas J Ford, NHS National Waiting Times Centre Board

RATATOUILLE Study (inteRnATional hAnd funcTiOn stUdy Following dIstaL radiaL accEss)

Traditionally, coronary angiograms are performed through the radial artery which is accessed above the palm of the 'right' hand. In recent years, some cardiologists are performing this procedure from the back of the wrist in as the radial artery courses through the anatomical snuffbox (distal radial access). The aim of this study is to determine the prevalence of hand dysfunction following coronary angiography via the distal radial artery.

Study Overview

Status

Completed

Detailed Description

In this multi centre observational registry, we will recruit patients undergoing planned invasive coronary angiography. Inclusion criteria include:

  1. Age ≥ 18 years.
  2. The distal radial artery must be palpable and non-occlusive flow must be confirmed by Doppler ultrasound.
  3. Patient should be able to comply with the protocol.
  4. Provide written informed consent before study participation.

The primary endpoint is the overall prevalence of hand dysfunction defined as any significant reduction from baseline score in any of the following five domains:

DASH score Levine Katz score VAS score Sensory function Pinch grip strength.

Specifically hand function will be assessed at 4 time points using simple tests of hand strength, sensation and ultrasound to assess the arterial latency.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glasgow, United Kingdom, G12 8QQ
        • University of Glasgow/Golden Jubilee Research Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Eligible patients for inclusion are those by whom coronary angiography or angioplasty is indicated as part of clinical decision-making or therapy. Operators with adequate experience at the discretion of the principal investigator in distal radial access are eligible to participate.

Description

Inclusion Criteria:

  1. Age ≥ 18 years.
  2. The distal radial artery must be palpable and non-occlusive flow must be confirmed by Doppler ultrasound.
  3. Patient should be able to comply with the protocol.
  4. Provide written informed consent before study participation.

Exclusion Criteria:

  1. Obligatory femoral or forearm radial access
  2. Previous ipsilateral forearm radial artery occlusion.
  3. Undergoing another procedure involving the ipsilateral radial artery, performed between the index procedure and the follow-up date.
  4. Enrolment in another study that competes or interferes with this study.
  5. Poor clinical condition like cardiogenic shock, that prohibits pre- and postprocedural function tests.
  6. Any other condition which, in the opinion of the investigator or operator, may pose a significant hazard to the subject if he or she is enrolled in the study.
  7. Co-morbidity that excludes patient follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Distal transradial arterial access
Patients undergoing invasive coronary angiography via the distal radial approach (anatomical snuffbox)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of hand dysfunction
Time Frame: 1 month
Any significant deterioration from baseline in hand function according to the 5 studied domains.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of distal radial access
Time Frame: Day 0
Successful introduction of sheath
Day 0
Vascular access complications (other than occlusion and bleeding)
Time Frame: Day 0
Surgical complications or clinically important vascular access complications
Day 0
Puncture time
Time Frame: Day 0
Time from skin puncture to successful placement of wire into the artery
Day 0
Radial artery occlusion - including level of occlusion (prox/distal)
Time Frame: 0-12 months
USS guide
0-12 months
Fluoroscopy time
Time Frame: Day 0
Minutes
Day 0
Hemostasis duration
Time Frame: Day 0
Minutes
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Ferdinand Kiemeneij, MD, MC Zuiderzee
  • Study Director: Ahmed Hassan, MD, MC Zuiderzee

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

December 26, 2018

First Submitted That Met QC Criteria

December 27, 2018

First Posted (Actual)

December 28, 2018

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 7, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nerve Injury

Subscribe